Skip to content

Study · Not a test of the peptide alone · 1994

1 result

[Cellular immunity in patients with gonorrhea and gonorrhea-chlamydia infection during treatment with pefloxacin in combination with thymogen].

Delektorskiĭ VV, Iashkova GN, Fedorov SM, Sammak UT, Lupan IN, Popova NV

Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]1 Jan 1994

PMID8060196 (opens in a new tab)PepBankPUB-08060196
Publisher pageAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Thymogen (oglufanide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymogen (oglufanide).

  1. 01HumanNot a test of Thymogen (oglufanide) aloneNon-randomized trialMechanism

    In gonorrheal-chlamydial infection, immunomodulator combinations with pefloxacin increased polymorph digestion function.

    In plain wordsIn patients with gonorrheal-chlamydial infection, immunomodulator combinations with pefloxacin increased immune-cell digestion function.

    Peptide
    Thymogen (oglufanide)
    Outcome
    IncreasePolymorph digestion function
    Study

    n: not reported in source

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    The morphometric analysis of the blood leukoconcentrate revealed an increase in the polymorph digestion function after the exposure to combinations of immunomodulators with abaktal
    1 context sentence
    Title · context
    [Cellular immunity in patients with gonorrhea and gonorrhea-chlamydia infection during treatment with pefloxacin in combination with thymogen].

    In this study, Thymogen (oglufanide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymogen (oglufanide).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.